Rizzo R - Search Results

1

Potential Associations Among Alteration of Salivary miRNAs, Saliva Microbiome Structure, and Cognitive Impairments in Autistic Children.

Ragusa M, Santagati M, Mirabella F, Lauretta G, Cirnigliaro M, Brex D, Barbagallo C, Domini CN, Gulisano M, Barone R, Trovato L, Oliveri S, Mongelli G, Spitale A, Barbagallo D, Di Pietro C, Stefani S, Rizzo R, Purrello M. Ragusa M, et al. Among authors: rizzo r. Int J Mol Sci. 2020 Aug 27;21(17):6203. doi: 10.3390/ijms21176203. Int J Mol Sci. 2020. PMID: 32867322 Free PMC article.

2

Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study.

Rizzo R, Gulisano M, Pavone P, Fogliani F, Robertson MM. Rizzo R, et al. J Child Neurol. 2006 Sep;21(9):747-53. doi: 10.1177/08830738060210091001. J Child Neurol. 2006. PMID: 16970879

3

Disentangling the effects of Tourette syndrome and attention deficit hyperactivity disorder on cognitive and behavioral phenotypes.

Rizzo R, Curatolo P, Gulisano M, Virzì M, Arpino C, Robertson MM. Rizzo R, et al. Brain Dev. 2007 Aug;29(7):413-20. doi: 10.1016/j.braindev.2006.12.003. Epub 2007 Feb 5. Brain Dev. 2007. PMID: 17280810

4

The successful use of ondansetron in a boy with both leukemia and Tourette syndrome.

Rizzo R, Marino S, Gulisano M, Robertson MM. Rizzo R, et al. J Child Neurol. 2008 Jan;23(1):108-11. doi: 10.1177/0883073807307085. J Child Neurol. 2008. PMID: 18184945

5

Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome.

Gulisano M, Calì PV, Cavanna AE, Eddy C, Rickards H, Rizzo R. Gulisano M, et al. Among authors: rizzo r. Neurol Sci. 2011 Dec;32(6):1213-7. doi: 10.1007/s10072-011-0678-1. Epub 2011 Jul 6. Neurol Sci. 2011. PMID: 21732066 Clinical Trial.

6

Long term clinical course of Tourette syndrome.

Rizzo R, Gulisano M, Calì PV, Curatolo P. Rizzo R, et al. Brain Dev. 2012 Sep;34(8):667-73. doi: 10.1016/j.braindev.2011.11.006. Epub 2011 Dec 16. Brain Dev. 2012. PMID: 22178151

7

Metabolic effects of aripiprazole and pimozide in children with Tourette syndrome.

Rizzo R, Eddy CM, Calí P, Gulisano M, Cavanna AE. Rizzo R, et al. Pediatr Neurol. 2012 Dec;47(6):419-22. doi: 10.1016/j.pediatrneurol.2012.08.015. Pediatr Neurol. 2012. PMID: 23127261

8

The effects of comorbid obsessive-compulsive disorder and attention-deficit hyperactivity disorder on quality of life in tourette syndrome.

Eddy CM, Cavanna AE, Gulisano M, Calì P, Robertson MM, Rizzo R. Eddy CM, et al. Among authors: rizzo r. J Neuropsychiatry Clin Neurosci. 2012 Fall;24(4):458-62. doi: 10.1176/appi.neuropsych.11080181. J Neuropsychiatry Clin Neurosci. 2012. PMID: 23224452

9

Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.

Rizzo R, Gulisano M, Calì PV, Curatolo P. Rizzo R, et al. Eur J Paediatr Neurol. 2013 Sep;17(5):421-8. doi: 10.1016/j.ejpn.2013.01.005. Epub 2013 Mar 7. Eur J Paediatr Neurol. 2013. PMID: 23473832 Review.

10

Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome.

Rizzo R, Gulisano M. Rizzo R, et al. Int Rev Neurobiol. 2013;112:415-44. doi: 10.1016/B978-0-12-411546-0.00014-7. Int Rev Neurobiol. 2013. PMID: 24295629 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

848 results

Search Page